Ernest Asante‐Appiah

2.6k total citations
47 papers, 1.6k citations indexed

About

Ernest Asante‐Appiah is a scholar working on Infectious Diseases, Molecular Biology and Hepatology. According to data from OpenAlex, Ernest Asante‐Appiah has authored 47 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 23 papers in Molecular Biology and 18 papers in Hepatology. Recurrent topics in Ernest Asante‐Appiah's work include HIV/AIDS drug development and treatment (25 papers), Hepatitis C virus research (18 papers) and HIV Research and Treatment (15 papers). Ernest Asante‐Appiah is often cited by papers focused on HIV/AIDS drug development and treatment (25 papers), Hepatitis C virus research (18 papers) and HIV Research and Treatment (15 papers). Ernest Asante‐Appiah collaborates with scholars based in United States, Canada and China. Ernest Asante‐Appiah's co-authors include Anna Marie Skalka, Brian P. Kennedy, A M Skalka, Giovanna Scapin, Kathryn Skorey, Yolanda Romsicki, Chidambaram Ramachandran, Sangita B. Patel, Paul Ingravallo and Qingping Wang and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Biochemistry.

In The Last Decade

Ernest Asante‐Appiah

46 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ernest Asante‐Appiah United States	21	958	655	493	343	293	47	1.6k
Shin-Lian Doong Taiwan	15	591 0.6×	528 0.8×	212 0.4×	176 0.5×	726 2.5×	27	1.6k
W. Gary Tarpley United States	28	1.2k 1.2×	1.5k 2.3×	1.5k 3.0×	153 0.4×	289 1.0×	57	2.9k
Boshi Huang China	23	624 0.7×	724 1.1×	570 1.2×	75 0.2×	396 1.4×	69	1.7k
Henri Moereels Belgium	14	441 0.5×	437 0.7×	290 0.6×	124 0.4×	213 0.7×	29	1.2k
Jinfa Du United States	18	677 0.7×	631 1.0×	84 0.2×	45 0.1×	430 1.5×	62	1.6k
Francesca Curreli United States	19	431 0.4×	503 0.8×	415 0.8×	145 0.4×	231 0.8×	38	1.2k
T.C. Appleby United States	22	775 0.8×	361 0.6×	65 0.1×	64 0.2×	272 0.9×	29	1.5k
Michele D. Sobolewski United States	14	499 0.5×	428 0.7×	582 1.2×	244 0.7×	135 0.5×	21	1.1k
Robert B. Perni United States	23	609 0.6×	424 0.6×	77 0.2×	70 0.2×	988 3.4×	49	2.4k
Preethi Krishnan United States	26	407 0.4×	734 1.1×	87 0.2×	41 0.1×	1.2k 4.2×	58	2.1k

Countries citing papers authored by Ernest Asante‐Appiah

Since Specialization

Citations

This map shows the geographic impact of Ernest Asante‐Appiah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ernest Asante‐Appiah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ernest Asante‐Appiah more than expected).

Fields of papers citing papers by Ernest Asante‐Appiah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ernest Asante‐Appiah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ernest Asante‐Appiah. The network helps show where Ernest Asante‐Appiah may publish in the future.

Co-authorship network of co-authors of Ernest Asante‐Appiah

This figure shows the co-authorship network connecting the top 25 collaborators of Ernest Asante‐Appiah. A scholar is included among the top collaborators of Ernest Asante‐Appiah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ernest Asante‐Appiah. Ernest Asante‐Appiah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rockstroh, Jürgen K., Roger Paredes, Pedro Cahn, et al.. (2025). Doravirine/Islatravir (100/0.75 mg) Once-Daily Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV-1 Treatment: 48-Week Results From a Phase 3, Randomized, Controlled, Double-Blind, Noninferiority Trial. Clinical Infectious Diseases. 81(2). 322–332.

Asante‐Appiah, Ernest, Hong Wan, Dongmei Yang, et al.. (2021). Impact of HIV-1 Resistance-Associated Mutations on Susceptibility to Doravirine: Analysis of Real-World Clinical Isolates. Antimicrobial Agents and Chemotherapy. 65(12). e0121621–e0121621. 11 indexed citations

Lawitz, Eric, Fred Poordad, Leah J. Anderson, et al.. (2019). Efficacy and safety of ruzasvir 60 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4 or 6 infection. Journal of Viral Hepatitis. 26(6). 675–684. 5 indexed citations

Yu, Wensheng, Bin Hu, Bin Zhong, et al.. (2019). Discovery of novel pan-genotypic HCV NS5A inhibitors containing a novel tetracyclic core. Bioorganic & Medicinal Chemistry Letters. 29(5). 700–706. 4 indexed citations

Zhou, Shuntai, David R. McGivern, Christina L. Burch, et al.. (2018). Evolutionary pathways to NS5A inhibitor resistance in genotype 1 hepatitis C virus. Antiviral Research. 158. 45–51. 4 indexed citations

Lai, Ming‐Tain, Paul Tawa, Anick Auger, et al.. (2017). Identification of novel bifunctional HIV-1 reverse transcriptase inhibitors. Journal of Antimicrobial Chemotherapy. 73(1). 109–117. 6 indexed citations

Guo, Zhuyan, Stuart Black, Yuan Hu, et al.. (2017). Unraveling the structural basis of grazoprevir potency against clinically relevant substitutions in hepatitis C virus NS3/4A protease from genotype 1a. Journal of Biological Chemistry. 292(15). 6202–6212. 8 indexed citations

McGivern, David R., Takahiro Masaki, Paul Ingravallo, et al.. (2014). Kinetic Analyses Reveal Potent and Early Blockade of Hepatitis C Virus Assembly by NS5A Inhibitors. Gastroenterology. 147(2). 453–462.e7. 84 indexed citations

Asante‐Appiah, Ernest, Sangita B. Patel, Caroline Desponts, et al.. (2006). Conformation-assisted Inhibition of Protein-tyrosine Phosphatase-1B Elicits Inhibitor Selectivity over T-cell Protein-tyrosine Phosphatase. Journal of Biological Chemistry. 281(12). 8010–8015. 36 indexed citations

10.

Montalibet, Jacqueline, et al.. (2005). Residues Distant from the Active Site Influence Protein-tyrosine Phosphatase 1B Inhibitor Binding. Journal of Biological Chemistry. 281(8). 5258–5266. 56 indexed citations

11.

Lau, Cheuk K., Christopher I. Bayly, Jacques Yves Gauthier, et al.. (2004). Structure based design of a series of potent and selective non peptidic PTP-1B inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(4). 1043–1048. 60 indexed citations

12.

Romsicki, Yolanda, et al.. (2004). Protein Tyrosine Phosphatase-1B Dephosphorylation of the Insulin Receptor Occurs in a Perinuclear Endosome Compartment in Human Embryonic Kidney 293 Cells. Journal of Biological Chemistry. 279(13). 12868–12875. 67 indexed citations

13.

Romsicki, Yolanda, Giovanna Scapin, Sangita B. Patel, et al.. (2003). Functional Characterization and Crystal Structure of the C215D Mutant of Protein-tyrosine Phosphatase-1B. Journal of Biological Chemistry. 278(31). 29009–29015. 9 indexed citations

14.

Romsicki, Yolanda, Brian P. Kennedy, & Ernest Asante‐Appiah. (2003). Purification and characterization of T cell protein tyrosine phosphatase reveals significant functional homology to protein tyrosine phosphatase-1B. Archives of Biochemistry and Biophysics. 414(1). 40–50. 20 indexed citations

15.

Asante‐Appiah, Ernest & Anna Marie Skalka. (1999). HIV-1 Integrase: Structural Organization, Conformational Changes, and Catalysis. Advances in virus research. 52. 351–369. 164 indexed citations

16.

Asante‐Appiah, Ernest, Steven H. Seeholzer, & Anna Marie Skalka. (1998). Structural Determinants of Metal-induced Conformational Changes in HIV-1 Integrase. Journal of Biological Chemistry. 273(52). 35078–35087. 45 indexed citations

17.

Asante‐Appiah, Ernest, George Merkel, & Anna Marie Skalka. (1998). Purification of Untagged Retroviral Integrases by Immobilized Metal Ion Affinity Chromatography. Protein Expression and Purification. 12(1). 105–110. 14 indexed citations

18.

Asante‐Appiah, Ernest & A M Skalka. (1997). Molecular mechanisms in retrovirus DNA integration. Antiviral Research. 36(3). 139–156. 123 indexed citations

19.

Asante‐Appiah, Ernest, J. Seetharaman, Frank Sicheri, Daniel S.C. Yang, & William W.‐C. Chan. (1997). gem-Dialkyl Succinic Acids: A Novel Class of Inhibitors for Carboxypeptidases. Biochemistry. 36(29). 8710–8715. 10 indexed citations

20.

Asante‐Appiah, Ernest & Anna Marie Skalka. (1997). A Metal-induced Conformational Change and Activation of HIV-1 Integrase. Journal of Biological Chemistry. 272(26). 16196–16205. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact